Author:
Yorsaeng Ritthideach,Suntronwong Nungruthai,Phowatthanasathian Harit,Assawakosri Suvichada,Kanokudom Sitthichai,Thongmee Thanunrat,Vichaiwattana Preeyaporn,Auphimai Chompoonut,Wongsrisang Lakkhana,Srimuan Donchida,Thatsanatorn Thaksaporn,Klinfueng Sirapa,Sudhinaraset Natthinee,Wanlapakorn Nasamon,Poovorawan Yong
Funder
King Chulalongkorn Memorial Hospital
Chulalongkorn University
National Research Council of Thailand
Health Systems Research Institute
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference26 articles.
1. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial;Zhang;Lancet Infect Dis,2021
2. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021
3. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines;Thompson;N Engl J Med,2021
4. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial;Al Kaabi;JAMA,2021
5. COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials;Yan;Pharmaceuticals (Basel),2021
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献